Target intelligence / Profile preview

Lipase

Molecular classification
Enzyme, Hydrolase, Alpha/beta-hydrolase fold enzyme, Esterase subclass
01

Overview

Lipases are a family of enzymes that catalyze the hydrolysis of ester bonds in triglycerides, converting them into free fatty acids and glycerol. They are essential for digestion, absorption, transport, and metabolism of dietary fats. Multiple types exist with tissue-specific functions—pancreatic lipases digest dietary fats in the small intestine; hepatic and hormone-sensitive forms regulate lipid stores in liver and adipose tissue; while endothelial/lipoprotein variants act on circulating triglyceride-rich particles. Structurally, most mammalian lipases share an alpha/beta-hydrolase fold with a catalytic triad typically composed of serine, histidine, and aspartic acid residues. Their activity is tightly regulated by conformational changes involving a lid domain that controls access to their active site. Clinically relevant both as biomarkers for diseases like pancreatitis and as therapeutic targets—most notably by drugs such as orlistat—they play key roles in metabolic health but can also be implicated in disorders ranging from cardiovascular disease to lysosomal storage syndromes.[1][3][5]

Other names
Triacylglycerol lipaseTriglyceride lipasePancreatic lipase (for the digestive isoform)Lipoprotein lipase (for the vascular isoform)Hepatic lipase (for the liver isoform)Hormone-sensitive lipase (for adipocyte isoform)
02

Mechanism of action

Inhibition of enzymatic hydrolysis of dietary triglycerides, reducing fat absorption in the intestine[1]

03

Biological functions

Hydrolysis of triglycerides into free fatty acids and glycerol[1][2][8]Digestion and absorption of dietary fats[1][3][8]Lipid transport and metabolism[1][5]Regulation of lipid storage in tissues[1][5]Cell signaling (phospholipases)[8]
04

Disease associations

Cardiovascular disease (e.g., dyslipidemia, atherosclerosis)[1]Obesity/metabolic syndrome[1]Pancreatitis (acute/chronic)[1]Lysosomal storage disorders (lysosomal acid lipase deficiency)[8]
05

Safety considerations

Inhibition may cause gastrointestinal side effects such as steatorrhea, diarrhea, or fat-soluble vitamin deficiencies when using inhibitors like orlistat[1]
06

Interacting drugs

Orlistat (pancreatic lipase inhibitor used for obesity treatment)[1]
07

Biomarkers

Serum/plasma pancreatic lipase levels for diagnosis of pancreatitis or pancreatic injury[1]

Beyond the preview

Go deeper on Lipase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call